Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer

por Armstrong, Cameron M., Gao, Allen C.
Publicado 2016

In honor of Dr. Donald S. Coffey – Prostate cancer biology and therapy

por Gao, Allen C., Mohler, James L.
Publicado 2019

Current strategies for targeting the activity of androgen receptor variants

por Armstrong, Cameron M., Gao, Allen C.
Publicado 2019

Targeting molecular resistance in castration-resistant prostate cancer

por Chandrasekar, Thenappan, Yang, Joy C., Gao, Allen C., Evans, Christopher P.
Publicado 2015

Mechanisms of resistance in castration-resistant prostate cancer (CRPC)

por Chandrasekar, Thenappan, Yang, Joy C., Gao, Allen C., Evans, Christopher P.
Publicado 2015

Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer

por Liu, Chengfei, Armstrong, Cameron, Zhu, Yezi, Lou, Wei, Gao, Allen C.
Publicado 2016

Stat3 enhances transactivation of steroid hormone receptors

por de Miguel, Fernando, Lee, Soo Ok, Onate, Sergio A, Gao, Allen C
Publicado 2003

Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy

por Cucchiara, Vito, Yang, Joy C., Mirone, Vincenzo, Gao, Allen C., Rosenfeld, Michael G., Evans, Christopher P.
Publicado 2017

The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy

por Messner, Elisabeth A., Steele, Thomas M., Tsamouri, Maria Malvina, Hejazi, Nazila, Gao, Allen C., Mudryj, Maria, Ghosh, Paramita M.
Publicado 2020

WLS-Wnt signaling promotes neuroendocrine prostate cancer

por Bland, Tyler, Wang, Jing, Yin, Lijuan, Pu, Tianjie, Li, Jingjing, Gao, Jin, Lin, Tzu-Ping, Gao, Allen C., Wu, Boyang Jason
Publicado 2021

Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient‐derived, advanced prostate cancer tissue xenograft model

por Qu, Sifeng, Wang, Kendric, Xue, Hui, Wang, Yuwei, Wu, Rebecca, Liu, Chengfei, Gao, Allen C., Gout, Peter W., Collins, Colin C., Wang, Yuzhuo
Publicado 2013

Therapeutic Resistance Models and Treatment Sequencing in Advanced Prostate Cancer

por Schaaf, Zachary A., Ning, Shu, Leslie, Amy R., Sharifi, Masuda, Han, Xianrui, Armstrong, Cameron, Lou, Wei, Lombard, Alan P., Liu, Chengfei, Gao, Allen C.
Publicado 2023

Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer

por Parikh, Mamta, Liu, Chengfei, Wu, Chun-Yi, Evans, Christopher P., Dall’Era, Marc, Robles, Daniel, Lara, Primo N., Agarwal, Neeraj, Gao, Allen C., Pan, Chong-Xian
Publicado 2021

Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer()

por Lombard, Alan P, Liu, Chengfei, Armstrong, Cameron M, D'Abronzo, Leandro S, Lou, Wei, Chen, Hongwu, Dall'Era, Marc, Ghosh, Paramita M, Evans, Christopher P, Gao, Allen C
Publicado 2019

Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models

por Xu, Pengfei, Yang, Joy C., Ning, Shu, Chen, Bo, Nip, Christopher, Wei, Qiang, Liu, Liangren, Johnson, Oleta T., Gao, Allen C., Gestwicki, Jason E., Evans, Christopher P., Liu, Chengfei
Publicado 2023

ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling

por Liu, Chengfei, Armstrong, Cameron M., Ning, Shu, Yang, Joy C., Lou, Wei, Lombard, Alan P., Zhao, Jinge, Wu, Chun-Yi, Yu, Aiming, Evans, Christopher P., Tepper, Clifford G., Li, Pui-kai, Gao, Allen C.
Publicado 2021

MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth

por Nadiminty, Nagalakshmi, Tummala, Ramakumar, Lou, Wei, Zhu, Yezi, Shi, Xu-Bao, Zou, June X., Chen, Hongwu, Zhang, Jin, Chen, Xinbin, Luo, Jun, deVere White, Ralph W., Kung, Hsing-Jien, Evans, Christopher P., Gao, Allen C.
Publicado 2012

Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer

por Liu, Chengfei, Lou, Wei, Yang, Joy C., Liu, Liangren, Armstrong, Cameron M., Lombard, Alan P., Zhao, Ruining, Noel, Onika D. V., Tepper, Clifford G., Chen, Hong-Wu, Dall’Era, Marc, Evans, Christopher P., Gao, Allen C.
Publicado 2018

Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes

por Ning, Shu, Zhao, Jinge, Lombard, Alan P., D’Abronzo, Leandro S., Leslie, Amy R., Sharifi, Masuda, Lou, Wei, Liu, Chengfei, Yang, Joy C., Evans, Christopher P., Corey, Eva, Chen, Hong-Wu, Yu, Aiming, Ghosh, Paramita M., Gao, Allen C.
Publicado 2022

ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer

por Wang, Junjian, Zou, June X., Xue, Xiaoqian, Cai, Demin, Zhang, Yan, Duan, Zhijian, Xiang, Qiuping, Yang, Joy C., Louie, Maggie C., Borowsky, Alexander D., Gao, Allen C., Evans, Christopher P., Lam, Kit S., Xu, Jianzhen, Kung, Hsing-Jien, Evans, Ronald M., Xu, Yong, Chen, Hong-Wu
Publicado 2016